In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

As a new research report from Colliers says, the role of retail pharmacies has changed over time, moving far beyond roles as ...

Online lenders tied to Native American tribes argue that they aren’t subject to state lending laws, but they backed away from ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug manufacturers for allegedly colluding to inflate the cost of insulin.

The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

A look back on the Biden administration’s most significant actions impacting food and farming during the president’s tenure.

The federal government is reportedly going after an apartment company with thousands of rental properties in metro Atlanta.

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.

Representative Ben Cline (R-VA) says the One Agency Act would house all antitrust authority under the Department of Justice. ...